Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ovarian Cancer Biomarkers: Moving Forward in Early Detection
Vasco D. B. Bonifácio
Advances in experimental medicine and biology (2020), pp. 355-363
Closed Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Applications of Proteomics in Ovarian Cancer: Dawn of a New Era
Aruni Ghose, Sri Vidya Niharika Gullapalli, Naila Chohan, et al.
Proteomes (2022) Vol. 10, Iss. 2, pp. 16-16
Open Access | Times Cited: 103
The emerging role of ferroptosis in female reproductive disorders
Min Liu, WU Ke-ming, Yeke Wu
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115415-115415
Open Access | Times Cited: 45
Emerging role of exosomes as biomarkers in cancer treatment and diagnosis
Niloofar Asadi Hanjani, Nazanin Esmaelizad, Saba Zanganeh, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 169, pp. 103565-103565
Closed Access | Times Cited: 87
Current Understanding on Why Ovarian Cancer Is Resistant to Immune Checkpoint Inhibitors
Anna Pawłowska, Anna K. Rekowska, Weronika Kuryło, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10859-10859
Open Access | Times Cited: 28
Challenges and Opportunities in Clinical Applications of Blood-Based Proteomics in Cancer
Ruchika Bhawal, Ann L. Oberg, Sheng Zhang, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2428-2428
Open Access | Times Cited: 64
Long non-coding RNA ADAMTS9-AS1 attenuates ferroptosis by Targeting microRNA-587/solute carrier family 7 member 11 axis in epithelial ovarian cancer
Cai Li, Xiaoqing Hu, Ye Lu, et al.
Bioengineered (2022) Vol. 13, Iss. 4, pp. 8226-8239
Open Access | Times Cited: 35
Mucins as Potential Biomarkers for Early Detection of Cancer
Shailendra K. Gautam, Parvez Κhan, Kavumpurathu Raman Thankappan, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1640-1640
Open Access | Times Cited: 21
Circulating ciRS-7 as a potential non-invasive biomarker for epithelial ovarian cancer: An investigative study
Aferin Beilerli, Sema Begliarzade, Albert Sufianov, et al.
Non-coding RNA Research (2022) Vol. 7, Iss. 3, pp. 197-204
Open Access | Times Cited: 26
A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer
Michael R. Kelly, Kamila Wiśniewska, Matthew J. Regner, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Stearoyl-CoA desaturase 1 inhibition induces ER stress-mediated apoptosis in ovarian cancer cells
Juwon Lee, Suin Jang, Jihye Im, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 5
A newly defined risk signature, consisting of three m6A RNA methylation regulators, predicts the prognosis of ovarian cancer
Lili Fan, Ying Lin, Lei Han, et al.
Aging (2020) Vol. 12, Iss. 18, pp. 18453-18475
Open Access | Times Cited: 34
BaP/BPDE suppresses human trophoblast cell migration/invasion and induces unexplained miscarriage by up-regulating a novel lnc-HZ11 in extracellular vesicles: An intercellular study
Chenyang Mi, Weina Chen, Ying Zhang, et al.
Environment International (2024) Vol. 188, pp. 108750-108750
Open Access | Times Cited: 4
Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer
Joohyun Ryu, Stefani N. Thomas
Molecules (2021) Vol. 26, Iss. 9, pp. 2674-2674
Open Access | Times Cited: 25
The Dual Blockade of the TIGIT and PD-1/PD-L1 Pathway as a New Hope for Ovarian Cancer Patients
Anna Pawłowska, Wiktoria Skiba, Dorota Suszczyk, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5757-5757
Open Access | Times Cited: 17
Meigs Syndrome and Elevated CA-125: Case Report and Literature Review of an Unusual Presentation Mimicking Ovarian Cancer
Irene Iavarone, Michela Padovano, Francesca Pasanisi, et al.
Medicina (2023) Vol. 59, Iss. 9, pp. 1684-1684
Open Access | Times Cited: 11
Opportunities for predictive proteogenomic biomarkers of drug treatment sensitivity in epithelial ovarian cancer
Trudy Janice Philips, Britt Erickson, Stefani N. Thomas
Frontiers in Oncology (2025) Vol. 14
Open Access
Investigation of the mechanism by which FOXJ2 inhibits proliferation, metastasis and cell cycle progression of ovarian cancer cells through the PI3K/AKT signaling pathway
Liyuan Wang, Han He, Ruifang Zhai, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Characterization of small extracellular vesicles from ovarian cancer patients and pre-diagnostic patient samples: Evidence from the Danish blood donor study
Nanna Lond Skov Frisk, Maléne Møller Jørgensen, Rikke Bæk, et al.
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0323529-e0323529
Open Access
CDC20 is a novel biomarker for improved clinical predictions in epithelial ovarian cancer.
Xiaoxue Xi, Tianyue Cao, Qian Yong-hong, et al.
PubMed (2022) Vol. 12, Iss. 7, pp. 3303-3317
Closed Access | Times Cited: 16
Exosome-related protein CRABP2 is upregulated in ovarian carcinoma and enhances cell proliferation
Ning Li, Guocui Lin, Ying Zhang, et al.
Discover Oncology (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Liquid biopsy in ovarian cancer: advantages and limitations for prognosis and diagnosis
Farzaneh Karimi, Omid Azadbakht, Ali Veisi, et al.
Medical Oncology (2023) Vol. 40, Iss. 9
Closed Access | Times Cited: 9
Sensitive and Cost‐Effective Tools in the Detection of Ovarian Cancer Biomarkers
Anis Elhami, Ahmad Mobed, Reza Soleimany, et al.
Analytical Science Advances (2024) Vol. 5, Iss. 9-10
Open Access | Times Cited: 3
BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation
Sihan Chen, Zhangyun Li, Yanyan Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
A Predictive Model for Initial Platinum‐Based Chemotherapy Efficacy in Patients with Postoperative Epithelial Ovarian Cancer Using Tissue‐Derived Small Extracellular Vesicles
Shizhen Shen, Conghui Wang, Jiaxin Gu, et al.
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 8
Open Access | Times Cited: 2
Copenhagen index (CPH-I) is more favorable than CA125, HE4, and risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models with clinical-ultrasonographic feature for diagnosing ovarian neoplasms
Zixuan Song, Xiaoxue Wang, Jiajun Fu, et al.
Frontiers in Surgery (2023) Vol. 9
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top